Work

Response to “Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A4*22 to Metabolism of Voriconazole”

Year: 2017

Type: letter

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.811

Authors: Thomas J. Walsh, Brad Moriyama, Scott R. Penzak, Teri E. Klein, Kelly E. Caudle

Institutions: Cornell University, Weill Cornell Medicine, Weill Cornell Medical Center, National Institutes of Health, National Institutes of Health Clinical Center, University of North Texas System, Stanford University, St. Jude Children's Research Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of General Medical Sciences

Award: PharmGKB: pharmacogenomics knowledge for precision medicine

OpenAlex ID: W2743359098

Cites: 7

Cited by: 10

Related to: 10